By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Vernalis PLC (Formerly Known As British Biotech PLC) 

Watlington Road

Oxford    OX4 5LY  United Kingdom
Phone: 01865-748747 Fax: 01865-781047


SEARCH JOBS




Collaborations

ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in anxiety and depression.





Company News
Vernalis PLC (VNLPY.PK) Change Of Year-End And Commercial Business Update 11/20/2014 2:36:06 PM
Vernalis PLC (VNLPY.PK) Announces CTI BioPharma Becomes Worldwide Licensee For Tosedostat 10/27/2014 11:04:44 AM
Vernalis PLC (VNLPY.PK) Opens US Office And Strengthens US Team With the Appointment Of SVP Medical Affairs 10/10/2014 11:55:42 AM
Vernalis PLC (VNLPY.PK) Release: FDA Accepts Tuzistra™ XR (CCP-01) NDA For Full Review 9/15/2014 8:30:40 AM
Vernalis PLC (VNLPY.PK) Release: Interim Results For The Six Months Ended 30 June 2014 8/6/2014 10:23:56 AM
Vernalis PLC (VNLPY.PK) And Servier Achieve Two Research Milestones In Their Oncology Collaborations 8/4/2014 11:24:28 AM
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014 7:45:21 AM
Vernalis PLC (VNLPY.PK): Notice Of Results For The Six Months Ended 30 June 2014 7/18/2014 11:03:05 AM
Vernalis PLC (VNLPY.PK) And Tris Pharma, Inc. Release: Submission Of Tuzistra™ XR (CCP-01) NDA To FDA 6/30/2014 9:15:29 AM
Vernalis PLC (VNLPY.PK) And Servier Achieve Research Milestone As BCL-2 Inhibitor Drug Candidate Enters Phase I 6/19/2014 9:01:10 AM
12345678910...
//-->